Dermatomyositis and polymyositis
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
... Other comorbid cancers commonly associated with DM are cancers of the lungs/mediastinum, bone/joints and kidney, as well as lymphoma and leukemia, with the SIRs ranging from 5 to 24. In contrast to the most com- monly ...
7
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
... with dermatomyositis and polymyositis, was performed using the Medical Research Council scale at baseline and at 3 ...of dermatomyositis and polymyositis received institutional review board ...
7
T cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
... Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp Hematol. 2009;37:266 – 75. 44. Walsh RJ, Kong SW, Yao Y, ...
15
<p>Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis</p>
... in Dermatomyositis and Polymyositis Treatment (ADAPT) registry reported responses to RCI treatment in 14 (58%) of 24 enrolled patients with refractory ...Cutaneous Dermatomyositis Disease Area and ...
8
Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis
... which dermatomyositis or polymyositis were identified as the underlying cause, we prepared special lists showing the causes involved in the respective natural histories [1,34-38], as well as those mentioned ...
15
Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis
... To assess the prevalence, characteristics and prognostic factors of interstitial lung disease (ILD) in Korean patients with polymyositis (PM), dermatomyositis (DM) and amyopathic dermato[r] ...
5
Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
... with polymyositis/dermatomyositis and hsa-miR- 4442 could be used as a biomarker for PM/DM diagnosis and/or disease ...MicroRNA, Polymyositis, Dermatomyositis, ...
9
Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
... Introduction Polymyositis and dermatomyositis (PM/DM) are the major inflammatory myositis in adults, which are characterized by chronic muscle inflammation/weakness. PM/DM, collectively known as idiopathic ...
9
Subcutaneous oedema as a presenting feature of polymyositis/dermatomyositis: a poor prognostic indicator?
... of polymyositis (PM)/dermato- myositis ...of dermatomyositis, briefly review the existing literature and postulate that this presentation represents a subset of the disease with a poorer ...
5
Previous Pulmonary Fibrosis in Dermatomyositis/Polymyositis: A Predictive Factor for Pulmonary and Extra Pulmonary Tuberculosis
... DOI: 10.4236/ojra.2018.84011 100 Open Journal of Rheumatology and Autoimmune Diseases Two or more sites were affected in 41.7% of cases. Conclusions: Previous pulmonary fibrosis in ...
12
Clinical significance of soluble CD163 in polymyositis related or dermatomyositis related interstitial lung disease
... Table 1 shows the correlation between serum sCD163 levels and other clinical factors at PM/DM-related ILD diagnosis. Although the coefficients were generally low, serum sCD163 was positively correlated with serum CRP (r ...
9
Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
... amyopathic dermatomyositis; CK: creatine kinase; CRP: C- reactive protein; DLco: diffusing capacity of the lung for carbon monoxide; DM: dermatomyositis; FVC: forced vital capacity; HRCT: high-resolution ...
10
Original Article Efficacy of infliximab plus conventional therapy in dermatomyositis/polymyositis with interstitial lung disease: a prospective cohort study
... of dermatomyositis/poly- myositis (DM/PM) and influences the ...on dermatomyositis/polymyositis (DM/PM) patients with interstitial lung disease ...
9
Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents
... Discussion In the present study, in which adult patients improved but none had recovered muscle strength at the follow- up biopsy, we found that immunosuppressive treatment of newly diagnosed PM and DM patients had ...
13
HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population
... dermatomyositis. J Rheumatol 1999, 26(12):2706 – 2709. 22. O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock ...
7
Original Article Comparative immunoprofiling of polymyositis and dermatomyositis muscles
... The present study aims to characterize the inflammatory profile of IIMs, including the expression of MHC-I, MHC-II, MAC and infiltrating cells.. We also investigated the sensitivity and[r] ...
10
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis
... A second factor leading to the statistical failure of the trial relates to the RPPD study design and the selection of the “placebo-phase” duration of 8 weeks chosen by the RIM Steering C[r] ...
15
The predictive prognostic factors for polymyositis/dermatomyositis associated interstitial lung disease
... amyopathic dermatomyositis; CAM: Cancer- associated myositis; CK: Creatine kinase; CMV: Cytomegalovirus; CT: Computed tomography; DM: Dermatomyositis; HRCT: High-resolution computed tomography; IIM: ...
10
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine
... When the oral corticosteroid group by was stratified dose, survival was similar between patients receiving < 60 versus ≥ 60 mg/day (data not shown)0. From 5 years onward, however, sur[r] ...
9
Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
... and dermatomyositis (DM) are in- flammatory systemic disorders characterized clinically by involvement of skeletal muscles, such as limb weakness and myalgia, with or without skin symptoms ...
6